1. Home
  2. MDWD vs WOLF Comparison

MDWD vs WOLF Comparison

Compare MDWD & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • WOLF
  • Stock Information
  • Founded
  • MDWD 2000
  • WOLF 1987
  • Country
  • MDWD Israel
  • WOLF United States
  • Employees
  • MDWD N/A
  • WOLF N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • WOLF Semiconductors
  • Sector
  • MDWD Health Care
  • WOLF Technology
  • Exchange
  • MDWD Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • MDWD 208.2M
  • WOLF 200.8M
  • IPO Year
  • MDWD 2014
  • WOLF 1993
  • Fundamental
  • Price
  • MDWD $16.70
  • WOLF $1.24
  • Analyst Decision
  • MDWD Strong Buy
  • WOLF Hold
  • Analyst Count
  • MDWD 2
  • WOLF 10
  • Target Price
  • MDWD $35.00
  • WOLF $8.39
  • AVG Volume (30 Days)
  • MDWD 94.5K
  • WOLF 8.0M
  • Earning Date
  • MDWD 08-14-2025
  • WOLF 08-25-2025
  • Dividend Yield
  • MDWD N/A
  • WOLF N/A
  • EPS Growth
  • MDWD N/A
  • WOLF N/A
  • EPS
  • MDWD N/A
  • WOLF N/A
  • Revenue
  • MDWD $19,858,000.00
  • WOLF $757,600,000.00
  • Revenue This Year
  • MDWD $20.37
  • WOLF $15.82
  • Revenue Next Year
  • MDWD $25.91
  • WOLF $16.47
  • P/E Ratio
  • MDWD N/A
  • WOLF N/A
  • Revenue Growth
  • MDWD N/A
  • WOLF N/A
  • 52 Week Low
  • MDWD $14.14
  • WOLF $0.39
  • 52 Week High
  • MDWD $22.51
  • WOLF $3.33
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 28.98
  • WOLF 41.71
  • Support Level
  • MDWD $16.62
  • WOLF $1.17
  • Resistance Level
  • MDWD $17.35
  • WOLF $1.46
  • Average True Range (ATR)
  • MDWD 0.73
  • WOLF 0.10
  • MACD
  • MDWD -0.08
  • WOLF -0.02
  • Stochastic Oscillator
  • MDWD 5.13
  • WOLF 24.14

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: